KLK3 and prostate cancer: A review estimated that as much as 25% of prostate cancer lesions detected on prostate biopsy are smaller than 1.0 cm3 and cannot be the reason for the increase in PSA that triggered the biopsy.25 Therefore, any screening program should be evaluated based on ability to detect clinically significant cancers.